Hims

HisRoom.net Blog Hims
Hims & Hers Stock Has Barely Moved Since Its Biggest Men’s Health Launch. Here’s What November 9 Has to Show
Men's Health

Hims & Hers Stock Has Barely Moved Since Its Biggest Men’s Health Launch. Here’s What November 9 Has to Show

Hims & Hers Health (HIMS) has barely moved since it launched injectable and oral testosterone replacement therapy (TRT) on October 21. The company called the launch the largest expansion of its men’s health program to date. Shares closed unchanged at $29.21 that day, then slipped 0.27% to $29.13 on October 22. They are down 10.29%…

Read More
A New Era for Testosterone Care: Hims launches new Injectable and Oral TRT options
Men's Health

A New Era for Testosterone Care: Hims launches new Injectable and Oral TRT options

When people hear the word 'testosterone,' the same image often comes to mind: physical strength, building muscle and hitting personal records in the gym. But that's not the full picture. Low testosterone impacts nearly 20 million men12 in the US, and for those affected, it can mean lower energy, reduced lean muscle, increased fat, lower…

Read More